Is fezolinetant produced in China?

Fezolinetant was originally jointly developed by the French pharmaceutical company Astellas Pharma and the American NeRRe Therapeutics. It is an innovative NK3 receptor antagonist developed internationally. It has been rigorously evaluated in the European and American clinical research and approval systems to ensure the efficacy and safety of the drug. So far, the main production and supply of fezonatant is handled by international pharmaceutical companies, and independent production of original drugs has not yet been fully achieved in China. If the drug needs to be used domestically, it is usually obtained through imported channels, or local supply may be achieved in the future through licensed production in China or the introduction of generic drugs.

The production of international original drugs strictly follows the GMP standards of the USFDA and European EMA, including full-process control of raw materials, production processes, stability and packaging. The production company adopts advanced chemical synthesis technology and high-standard quality management system to ensure that the purity, dissolution rate and active ingredients of each batch of drugs meet strict requirements. This production system not only ensures the consistency of drug efficacy worldwide, but also reduces potential quality risks in production, providing reliable protection for patients. In addition, the drug research and development of international manufacturers is usually equipped with a complete drug monitoring and safety tracking system, so that long-term safety assessments can be carried out after the drug is launched, further enhancing patients' confidence in drug use.

At present, there is no domestically produced original version of Zonatant on the Chinese domestic market. At the same time, domestic medical institutions may also gradually introduce generic drugs with policy and regulatory permission to increase the flexibility and economy of patient choice. At the same time, patients should ensure that the channels are regular and avoid unlicensed products when choosing fezonatan to ensure drug quality and safety, and use it under the guidance of professional doctors to obtain the best efficacy and long-term management effects.

Reference materials:https://www.veozah.com/